GTBPVSHCA• 12 Months (Normalized)
GTBP vs HCA (GT Biopharma Inc. vs HCA Healthcare Inc.)
Showing Closing Date Range from Oct 6, 2025 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.37
+802.27%
GT Biopharma Inc.
Normalized Baseline0.00%
HCA Performance $432.2
-0.31%
HCA Healthcare Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+802.58 pts
GTBP outperforming by 802.58 percentage points
GTBPHCA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP HCA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | GTBP Price | GTBP Gain (%) | HCA Price | HCA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $6.37 | +802.27% | $432.20 | -0.31% | +802.58% |
| Oct 05, 2026 | $6.16 | +772.52% | $434.92 | +0.32% | +772.20% |
| Oct 02, 2026 | $6.10 | +764.02% | $426.69 | -1.58% | +765.60% |
| Sep 30, 2026 | $- | $430.43 | -0.72% | - | |
| Sep 29, 2026 | $6.88 | +873.80% | $431.63 | -0.44% | +874.24% |
| Sep 28, 2026 | $6.80 | +863.17% | $432.60 | -0.22% | +863.39% |
| Sep 25, 2026 | $6.89 | +875.92% | $435.61 | +0.48% | +875.44% |
| Sep 24, 2026 | $6.83 | +867.42% | $423.48 | -2.32% | +869.74% |
| Sep 23, 2026 | $7.10 | +905.67% | $436.48 | +0.68% | +904.99% |
| Sep 22, 2026 | $- | $438.12 | +1.05% | - | |
| Sep 21, 2026 | $7.18 | +917.00% | $425.97 | -1.75% | +918.75% |
| Sep 18, 2026 | $7.16 | +914.16% | $427.71 | -1.35% | +915.51% |
| Sep 17, 2026 | $7.49 | +960.91% | $429.04 | -1.04% | +961.95% |
| Sep 16, 2026 | $7.81 | +1006.23% | $430.43 | -0.72% | +1006.95% |
| Sep 15, 2026 | $9.00 | +1174.79% | $423.82 | -2.24% | +1177.03% |
Page 1 of 17